Use Options For a Chance To Buy CLVS at a 43% Discount

Looking back to 6 days ago, Clovis Oncology Inc (CLVS) priced a 3,525,641 share secondary stock offering at $78.00 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the course of time and based on early trading on Tuesday, the stock is now 7.9% above the offering price..